| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 93 | 2024 | 1774 | 6.780 |
Why?
|
| Pregnancy Trimester, First | 12 | 2024 | 919 | 1.940 |
Why?
|
| Down Syndrome | 20 | 2023 | 915 | 1.920 |
Why?
|
| Fetus | 16 | 2019 | 1870 | 1.770 |
Why?
|
| Aneuploidy | 13 | 2024 | 578 | 1.720 |
Why?
|
| Fetal Diseases | 36 | 2014 | 914 | 1.600 |
Why?
|
| Nuchal Translucency Measurement | 8 | 2024 | 59 | 1.590 |
Why?
|
| Ultrasonography | 14 | 2019 | 5993 | 1.000 |
Why?
|
| Pregnancy Trimester, Second | 20 | 2022 | 737 | 0.960 |
Why?
|
| Pregnancy | 108 | 2024 | 30260 | 0.950 |
Why?
|
| Genital Diseases, Female | 3 | 2019 | 193 | 0.940 |
Why?
|
| Trisomy | 8 | 2023 | 259 | 0.880 |
Why?
|
| Pelvic Pain | 2 | 2019 | 300 | 0.820 |
Why?
|
| Urinary Tract | 3 | 2022 | 305 | 0.760 |
Why?
|
| Karyotyping | 18 | 2016 | 1178 | 0.750 |
Why?
|
| Uterus | 5 | 2021 | 661 | 0.700 |
Why?
|
| Genitalia, Female | 2 | 2019 | 147 | 0.650 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2019 | 4034 | 0.620 |
Why?
|
| Gestational Age | 33 | 2021 | 3609 | 0.610 |
Why?
|
| Obstetrics | 7 | 2024 | 680 | 0.590 |
Why?
|
| Adnexal Diseases | 1 | 2017 | 104 | 0.520 |
Why?
|
| Intrauterine Devices | 3 | 2019 | 115 | 0.520 |
Why?
|
| Chromosome Disorders | 6 | 2016 | 498 | 0.480 |
Why?
|
| Crown-Rump Length | 5 | 2023 | 31 | 0.460 |
Why?
|
| Quality Assurance, Health Care | 5 | 2021 | 2172 | 0.450 |
Why?
|
| Credentialing | 1 | 2014 | 118 | 0.440 |
Why?
|
| Pregnancy Outcome | 18 | 2023 | 2966 | 0.440 |
Why?
|
| Abortion, Induced | 3 | 2017 | 471 | 0.440 |
Why?
|
| Endometriosis | 3 | 2015 | 870 | 0.430 |
Why?
|
| Teratoma | 2 | 2016 | 401 | 0.420 |
Why?
|
| Perinatology | 2 | 2022 | 64 | 0.400 |
Why?
|
| DNA | 3 | 2016 | 7202 | 0.400 |
Why?
|
| Pregnancy Trimester, Third | 9 | 2022 | 587 | 0.390 |
Why?
|
| Genetic Counseling | 1 | 2016 | 634 | 0.390 |
Why?
|
| Nasal Bone | 2 | 2019 | 58 | 0.370 |
Why?
|
| Intestinal Diseases | 2 | 2015 | 506 | 0.370 |
Why?
|
| Myometrium | 3 | 2010 | 175 | 0.360 |
Why?
|
| Oligohydramnios | 3 | 2001 | 37 | 0.360 |
Why?
|
| Female | 122 | 2024 | 396112 | 0.360 |
Why?
|
| Fetal Death | 5 | 2010 | 435 | 0.350 |
Why?
|
| Choice Behavior | 1 | 2016 | 844 | 0.340 |
Why?
|
| Maternal Age | 9 | 2003 | 804 | 0.330 |
Why?
|
| Genetic Testing | 9 | 2019 | 3595 | 0.320 |
Why?
|
| Uterine Hemorrhage | 2 | 2009 | 235 | 0.320 |
Why?
|
| Restraint, Physical | 1 | 2010 | 186 | 0.310 |
Why?
|
| Fetal Heart | 5 | 2000 | 281 | 0.310 |
Why?
|
| Foreign-Body Migration | 2 | 2010 | 220 | 0.300 |
Why?
|
| Amniotic Fluid | 3 | 2007 | 380 | 0.290 |
Why?
|
| Yolk Sac | 2 | 1999 | 79 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 18 | 6 | 2016 | 247 | 0.280 |
Why?
|
| Diagnosis, Differential | 17 | 2019 | 12976 | 0.280 |
Why?
|
| Uterine Diseases | 1 | 2008 | 108 | 0.280 |
Why?
|
| Micrognathism | 2 | 2019 | 63 | 0.270 |
Why?
|
| Hydronephrosis | 3 | 2022 | 274 | 0.270 |
Why?
|
| Ultrasonography, Doppler | 3 | 2015 | 460 | 0.270 |
Why?
|
| Extraembryonic Membranes | 2 | 1999 | 37 | 0.260 |
Why?
|
| Gravidity | 2 | 2019 | 50 | 0.260 |
Why?
|
| Nose | 3 | 2019 | 519 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2016 | 191 | 0.250 |
Why?
|
| Humans | 126 | 2024 | 765968 | 0.250 |
Why?
|
| Ovarian Neoplasms | 4 | 2016 | 4900 | 0.240 |
Why?
|
| Chromosome Aberrations | 7 | 2018 | 1774 | 0.240 |
Why?
|
| Prenatal Diagnosis | 3 | 2023 | 1268 | 0.230 |
Why?
|
| Image Enhancement | 3 | 2010 | 2858 | 0.230 |
Why?
|
| Retrospective Studies | 35 | 2023 | 81514 | 0.230 |
Why?
|
| Twins, Monozygotic | 2 | 1996 | 469 | 0.230 |
Why?
|
| Amniocentesis | 6 | 2001 | 116 | 0.220 |
Why?
|
| Face | 2 | 2019 | 1028 | 0.210 |
Why?
|
| Adult | 50 | 2024 | 223044 | 0.210 |
Why?
|
| Pelvis | 2 | 2015 | 738 | 0.210 |
Why?
|
| Polyhydramnios | 4 | 1996 | 41 | 0.200 |
Why?
|
| Dilatation, Pathologic | 3 | 2019 | 527 | 0.200 |
Why?
|
| Aicardi Syndrome | 1 | 2022 | 16 | 0.190 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.190 |
Why?
|
| Predictive Value of Tests | 14 | 2016 | 15398 | 0.190 |
Why?
|
| Observer Variation | 4 | 2019 | 2615 | 0.190 |
Why?
|
| Consensus | 4 | 2022 | 3202 | 0.190 |
Why?
|
| Abnormalities, Multiple | 7 | 2002 | 1424 | 0.180 |
Why?
|
| Delivery, Obstetric | 8 | 2019 | 946 | 0.180 |
Why?
|
| Sensitivity and Specificity | 16 | 2021 | 14652 | 0.170 |
Why?
|
| Pregnancy Complications | 4 | 2014 | 2975 | 0.170 |
Why?
|
| Polydactyly | 1 | 2000 | 57 | 0.170 |
Why?
|
| Hypertelorism | 1 | 2019 | 29 | 0.170 |
Why?
|
| Anophthalmos | 1 | 2019 | 23 | 0.170 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 243 | 0.170 |
Why?
|
| Clinical Competence | 5 | 2022 | 4863 | 0.170 |
Why?
|
| Toes | 1 | 2000 | 209 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2001 | 453 | 0.160 |
Why?
|
| Microphthalmos | 1 | 2019 | 58 | 0.160 |
Why?
|
| Cause of Death | 1 | 2010 | 3708 | 0.160 |
Why?
|
| Corpus Callosum | 3 | 2022 | 751 | 0.160 |
Why?
|
| Pregnancy, High-Risk | 4 | 2003 | 121 | 0.160 |
Why?
|
| Amnion | 2 | 2001 | 204 | 0.150 |
Why?
|
| Urine | 1 | 2000 | 360 | 0.150 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 1998 | 25 | 0.150 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26346 | 0.150 |
Why?
|
| Femur | 4 | 2002 | 1310 | 0.150 |
Why?
|
| Cesarean Section | 5 | 2021 | 1431 | 0.150 |
Why?
|
| Cleft Lip | 2 | 2019 | 511 | 0.150 |
Why?
|
| Pregnancy, Multiple | 2 | 1996 | 216 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 1997 | 258 | 0.140 |
Why?
|
| Cleft Palate | 2 | 2019 | 591 | 0.140 |
Why?
|
| Fingers | 1 | 2000 | 509 | 0.140 |
Why?
|
| Cryptorchidism | 1 | 1998 | 152 | 0.140 |
Why?
|
| Placenta Accreta | 1 | 2021 | 242 | 0.140 |
Why?
|
| Cerebral Ventricles | 2 | 2007 | 549 | 0.140 |
Why?
|
| Ultrasonics | 1 | 2018 | 209 | 0.130 |
Why?
|
| Varicose Veins | 1 | 1998 | 158 | 0.130 |
Why?
|
| Cervix Uteri | 2 | 2010 | 579 | 0.130 |
Why?
|
| Orbit | 1 | 2019 | 456 | 0.130 |
Why?
|
| Endosonography | 1 | 2000 | 626 | 0.130 |
Why?
|
| Choroid Plexus | 2 | 1996 | 250 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2016 | 116 | 0.130 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 1995 | 42 | 0.130 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 1995 | 43 | 0.130 |
Why?
|
| Gynecology | 2 | 2021 | 535 | 0.120 |
Why?
|
| Foot Deformities, Congenital | 1 | 1995 | 59 | 0.120 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 20124 | 0.120 |
Why?
|
| Cell-Free System | 1 | 2016 | 339 | 0.120 |
Why?
|
| Renal Veins | 1 | 2015 | 103 | 0.120 |
Why?
|
| Fetofetal Transfusion | 1 | 1996 | 119 | 0.120 |
Why?
|
| Fetal Growth Retardation | 3 | 1994 | 591 | 0.120 |
Why?
|
| Skinfold Thickness | 1 | 1995 | 164 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2016 | 573 | 0.120 |
Why?
|
| Diseases in Twins | 1 | 1996 | 448 | 0.120 |
Why?
|
| Virilism | 1 | 1994 | 28 | 0.120 |
Why?
|
| Hand Deformities, Congenital | 1 | 1995 | 175 | 0.120 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1995 | 215 | 0.110 |
Why?
|
| Organ Size | 2 | 2010 | 2260 | 0.110 |
Why?
|
| Curriculum | 3 | 2022 | 3782 | 0.110 |
Why?
|
| Abdominal Muscles | 1 | 1995 | 172 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2000 | 1154 | 0.110 |
Why?
|
| Cysts | 2 | 1996 | 684 | 0.110 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1994 | 94 | 0.110 |
Why?
|
| Ovarian Diseases | 1 | 2014 | 131 | 0.110 |
Why?
|
| Echocardiography | 3 | 1995 | 5045 | 0.100 |
Why?
|
| Acoustics | 1 | 2014 | 235 | 0.100 |
Why?
|
| Hernia, Umbilical | 1 | 1993 | 102 | 0.100 |
Why?
|
| Placenta Diseases | 1 | 1994 | 199 | 0.100 |
Why?
|
| Quality Improvement | 2 | 2018 | 3853 | 0.100 |
Why?
|
| Urologic Diseases | 1 | 2014 | 245 | 0.100 |
Why?
|
| Endometrium | 2 | 2008 | 406 | 0.100 |
Why?
|
| Prognosis | 14 | 2019 | 29922 | 0.090 |
Why?
|
| Abortion, Spontaneous | 3 | 1996 | 536 | 0.090 |
Why?
|
| Premature Birth | 1 | 2023 | 1829 | 0.090 |
Why?
|
| Intrauterine Device Migration | 1 | 2010 | 5 | 0.090 |
Why?
|
| Microcephaly | 1 | 1995 | 426 | 0.090 |
Why?
|
| Dwarfism | 1 | 1991 | 137 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1261 | 0.090 |
Why?
|
| Prospective Studies | 18 | 2002 | 54802 | 0.080 |
Why?
|
| Safety | 1 | 2014 | 1157 | 0.080 |
Why?
|
| Likelihood Functions | 2 | 2002 | 993 | 0.080 |
Why?
|
| Dandy-Walker Syndrome | 3 | 2000 | 44 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 2176 | 0.080 |
Why?
|
| Sex Characteristics | 3 | 1998 | 2643 | 0.080 |
Why?
|
| Thyroid Diseases | 1 | 1992 | 388 | 0.070 |
Why?
|
| Placenta | 3 | 2021 | 1728 | 0.070 |
Why?
|
| Aspirin | 1 | 2020 | 3134 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 2770 | 0.070 |
Why?
|
| Cerebellum | 1 | 1994 | 1518 | 0.070 |
Why?
|
| Parity | 1 | 2010 | 931 | 0.070 |
Why?
|
| Seizures | 1 | 2000 | 3000 | 0.070 |
Why?
|
| Ilium | 2 | 1998 | 154 | 0.070 |
Why?
|
| Middle Aged | 12 | 2018 | 223009 | 0.070 |
Why?
|
| Follow-Up Studies | 13 | 1999 | 39193 | 0.070 |
Why?
|
| Premenopause | 1 | 2010 | 1037 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 3432 | 0.060 |
Why?
|
| Chorion | 2 | 1996 | 113 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1327 | 0.060 |
Why?
|
| Syndrome | 3 | 2000 | 3271 | 0.060 |
Why?
|
| Infant | 4 | 2023 | 36386 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1996 | 521 | 0.060 |
Why?
|
| Sex Preselection | 1 | 2004 | 15 | 0.060 |
Why?
|
| Intestines | 1 | 1994 | 1906 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 1992 | 1180 | 0.060 |
Why?
|
| Reference Values | 2 | 2010 | 4908 | 0.060 |
Why?
|
| Fellowships and Scholarships | 2 | 2022 | 1135 | 0.050 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 226 | 0.050 |
Why?
|
| Umbilical Cord | 2 | 1995 | 180 | 0.050 |
Why?
|
| Meconium | 2 | 1994 | 47 | 0.050 |
Why?
|
| Twins, Dizygotic | 1 | 2023 | 236 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7425 | 0.050 |
Why?
|
| Frontal Bone | 1 | 2002 | 105 | 0.050 |
Why?
|
| Adolescent | 5 | 2018 | 88835 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 24282 | 0.050 |
Why?
|
| Arthrogryposis | 1 | 2002 | 70 | 0.050 |
Why?
|
| Fathers | 1 | 2004 | 376 | 0.050 |
Why?
|
| Physician Assistants | 1 | 2003 | 190 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2098 | 0.040 |
Why?
|
| Dilatation | 1 | 2022 | 310 | 0.040 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2001 | 94 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2002 | 1831 | 0.040 |
Why?
|
| Kidney | 2 | 2011 | 7066 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1673 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2016 | 41649 | 0.040 |
Why?
|
| Pregnancy Tests | 1 | 1999 | 33 | 0.040 |
Why?
|
| Polyps | 1 | 2001 | 200 | 0.040 |
Why?
|
| Neck | 2 | 1995 | 733 | 0.040 |
Why?
|
| Heart Defects, Congenital | 2 | 1995 | 4697 | 0.040 |
Why?
|
| Lung | 1 | 1997 | 10033 | 0.040 |
Why?
|
| Abortion, Eugenic | 1 | 1998 | 39 | 0.040 |
Why?
|
| United States | 6 | 2024 | 72903 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 1 | 1999 | 146 | 0.040 |
Why?
|
| Diploidy | 1 | 1998 | 141 | 0.040 |
Why?
|
| Choroid | 1 | 2000 | 363 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2017 | 5946 | 0.030 |
Why?
|
| Mothers | 2 | 2004 | 2210 | 0.030 |
Why?
|
| X Chromosome | 1 | 2000 | 819 | 0.030 |
Why?
|
| Biometry | 2 | 2001 | 571 | 0.030 |
Why?
|
| Esophageal Cyst | 1 | 1995 | 13 | 0.030 |
Why?
|
| Endocardial Fibroelastosis | 1 | 1996 | 66 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1600 | 0.030 |
Why?
|
| Odds Ratio | 2 | 1998 | 9649 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2000 | 643 | 0.030 |
Why?
|
| Risk Factors | 8 | 2020 | 74840 | 0.030 |
Why?
|
| Mediastinal Diseases | 1 | 1995 | 91 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1996 | 353 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2121 | 0.030 |
Why?
|
| ROC Curve | 1 | 2002 | 3620 | 0.030 |
Why?
|
| Cicatrix | 1 | 2021 | 798 | 0.030 |
Why?
|
| Genitalia | 1 | 1995 | 114 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2000 | 2341 | 0.030 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 1994 | 37 | 0.030 |
Why?
|
| Vernix Caseosa | 1 | 1994 | 5 | 0.030 |
Why?
|
| Hemorrhage | 2 | 1998 | 3461 | 0.030 |
Why?
|
| Vagina | 1 | 2000 | 848 | 0.030 |
Why?
|
| Head | 1 | 2000 | 925 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 1998 | 3832 | 0.030 |
Why?
|
| Accreditation | 1 | 2017 | 477 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 419 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2020 | 532 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1995 | 235 | 0.030 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1994 | 164 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 18380 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2005 | 8733 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 1995 | 267 | 0.030 |
Why?
|
| Pulmonary Atresia | 1 | 1994 | 159 | 0.030 |
Why?
|
| Lymphangioma | 1 | 1993 | 60 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1994 | 323 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2002 | 1582 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2021 | 2499 | 0.030 |
Why?
|
| Obstetric Labor, Premature | 1 | 1994 | 268 | 0.030 |
Why?
|
| Hysterectomy | 1 | 1998 | 864 | 0.030 |
Why?
|
| Collagen | 1 | 2001 | 2618 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 59889 | 0.030 |
Why?
|
| Humerus | 1 | 1995 | 272 | 0.030 |
Why?
|
| Linear Models | 1 | 2002 | 5876 | 0.030 |
Why?
|
| Congenital Abnormalities | 4 | 2000 | 704 | 0.030 |
Why?
|
| Prevalence | 4 | 2000 | 15842 | 0.030 |
Why?
|
| Survival Rate | 3 | 1995 | 12795 | 0.030 |
Why?
|
| Decidua | 1 | 1992 | 80 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 533 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65188 | 0.020 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1994 | 262 | 0.020 |
Why?
|
| Placenta Previa | 1 | 1994 | 125 | 0.020 |
Why?
|
| Pierre Robin Syndrome | 1 | 1994 | 112 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1998 | 2910 | 0.020 |
Why?
|
| Time Factors | 2 | 2021 | 40065 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 36532 | 0.020 |
Why?
|
| Goiter | 1 | 1992 | 86 | 0.020 |
Why?
|
| Duodenum | 1 | 1995 | 495 | 0.020 |
Why?
|
| Cephalometry | 1 | 1993 | 380 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2000 | 1421 | 0.020 |
Why?
|
| Hernia, Ventral | 1 | 1995 | 220 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 1991 | 78 | 0.020 |
Why?
|
| Prolactin | 1 | 1992 | 625 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2418 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 2 | 1995 | 2921 | 0.020 |
Why?
|
| Brain Diseases | 2 | 1996 | 1546 | 0.020 |
Why?
|
| Mitral Valve Prolapse | 1 | 1991 | 213 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 1992 | 253 | 0.020 |
Why?
|
| Hemangioma | 1 | 1994 | 723 | 0.020 |
Why?
|
| Peritonitis | 1 | 1992 | 369 | 0.020 |
Why?
|
| Tachycardia | 1 | 1991 | 594 | 0.020 |
Why?
|
| Retina | 1 | 2000 | 2657 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2021 | 3956 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15880 | 0.020 |
Why?
|
| Urology | 1 | 2012 | 384 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1995 | 1263 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1993 | 1214 | 0.020 |
Why?
|
| Male | 10 | 2015 | 363698 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1995 | 1303 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 1995 | 1240 | 0.020 |
Why?
|
| Calcinosis | 1 | 1995 | 1479 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5526 | 0.020 |
Why?
|
| Colon | 1 | 1995 | 1795 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 2136 | 0.020 |
Why?
|
| Postmenopause | 1 | 1994 | 2515 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1992 | 1936 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2012 | 1160 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1996 | 2023 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10383 | 0.010 |
Why?
|
| Organizational Case Studies | 1 | 2003 | 299 | 0.010 |
Why?
|
| Professional Autonomy | 1 | 2003 | 172 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1991 | 1414 | 0.010 |
Why?
|
| Family Planning Services | 1 | 2004 | 278 | 0.010 |
Why?
|
| Religion | 1 | 2004 | 376 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 766 | 0.010 |
Why?
|
| Labor Presentation | 1 | 2000 | 54 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2000 | 42500 | 0.010 |
Why?
|
| Mutation | 2 | 2001 | 30198 | 0.010 |
Why?
|
| Radiology | 1 | 2012 | 2090 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 18071 | 0.010 |
Why?
|
| Pediatrics | 1 | 2012 | 3606 | 0.010 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1996 | 137 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1995 | 228 | 0.010 |
Why?
|
| Facial Neoplasms | 1 | 1995 | 127 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1977 | 665 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2794 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2000 | 974 | 0.010 |
Why?
|
| Logistic Models | 2 | 2000 | 13266 | 0.010 |
Why?
|
| Anthropometry | 1 | 1998 | 1338 | 0.010 |
Why?
|
| Rotation | 1 | 1995 | 513 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 1993 | 113 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1381 | 0.010 |
Why?
|
| Propafenone | 1 | 1991 | 27 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1992 | 515 | 0.010 |
Why?
|
| Boston | 1 | 2004 | 9338 | 0.010 |
Why?
|
| Child | 1 | 2000 | 80564 | 0.010 |
Why?
|
| Hematoma | 1 | 1996 | 766 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7838 | 0.010 |
Why?
|
| Eating | 1 | 1977 | 1540 | 0.010 |
Why?
|
| Massachusetts | 1 | 2003 | 8875 | 0.010 |
Why?
|
| Heart Failure | 1 | 1994 | 11840 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 6897 | 0.010 |
Why?
|
| Ascites | 1 | 1992 | 336 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 2475 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1995 | 836 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1991 | 1263 | 0.000 |
Why?
|
| Bayes Theorem | 1 | 1995 | 2354 | 0.000 |
Why?
|
| Body Weight | 1 | 1977 | 4622 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1992 | 6203 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1992 | 6322 | 0.000 |
Why?
|
| Cystic Fibrosis | 1 | 1992 | 1287 | 0.000 |
Why?
|
| Recurrence | 1 | 1991 | 8501 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1991 | 6404 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1995 | 22223 | 0.000 |
Why?
|
| Incidence | 1 | 1994 | 21480 | 0.000 |
Why?
|
| Brain | 1 | 2000 | 27171 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1977 | 8102 | 0.000 |
Why?
|
| Homeostasis | 1 | 1977 | 3336 | 0.000 |
Why?
|
| Rats | 1 | 1977 | 23707 | 0.000 |
Why?
|
| Animals | 1 | 1977 | 168764 | 0.000 |
Why?
|